SLC5A5 and thyroid gland carcinoma: Loss of NIS expression, primarily driven by activated MAPK and PI3K/Akt pathways, is a hallmark of dedifferentiation and a primary cause of RAI resistance in advanced thyroid cancers [6,10,64].